Nine Energy Service, Inc. Common Stock (NINE)
0.9600
-0.0800 (-7.69%)
NYSE · Last Trade: Apr 5th, 11:41 AM EDT

Via Benzinga · January 22, 2025

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on revenue of $366.82 million.
Via Benzinga · November 6, 2023

Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million.
Via Benzinga · August 3, 2023

Stocks gave back all of Monday’s gains and then some today. Monday’s panic buyers were mercilessly punished for going nuts during the spree.
Via Talk Markets · January 8, 2025

Via Benzinga · January 3, 2025

Clarivate, Prospect Capital, and Nine Energy Service insiders bought millions in stock. See what’s driving this insider confidence.
Via MarketBeat · December 10, 2024

Via Benzinga · August 8, 2024

NINE stock results show that Nine Energy Service missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via InvestorPlace · August 5, 2024

NINE stock results show that Nine Energy Service beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via InvestorPlace · May 6, 2024

NINE stock results show that Nine Energy Service beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.
Via InvestorPlace · March 7, 2024

The most oversold stocks in the energy sector presents an opportunity to buy into undervalued companies.
Via Benzinga · November 15, 2023

Gainers Blue Apron Holdings, Inc. (NASDAQ: APRN) climbed 133.5% to $12.82 after the company announced an agreement to be acquired by Wonder Group for $13 per share.
Via Benzinga · September 29, 2023

Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million.
Via Benzinga · March 7, 2024

Gainers PaxMedica, Inc. (NASDAQ: PXMD) shares climbed 173.8% to $8.35. PaxMedica announced the publication of its autism spectrum disorder Phase 2 study results in the Annals of General Psychiatry.
Via Benzinga · November 7, 2023

Although the concept of short-squeeze stocks is one best left for speculators, these ideas have a touch of rationality behind them.
Via InvestorPlace · September 6, 2023

U.S. stocks traded higher this morning, with Dow Jones gaining over 100 points on Tuesday. Following the market opening Tuesday, the Dow traded up 0.32% to 34,173.85 while the NASDAQ rose 0.72% to 13,559.01. The S&P 500, also rose, gaining, 0.49% to 4,360.39.
Via Benzinga · June 13, 2023

U.S. stocks traded mixed toward the end of trading, with Dow Jones gaining around 100 points on Wednesday. The Dow traded up 0.30% to 33,672.74 while the NASDAQ fell 1.11% to 13,129.19. The S&P 500, also fell, dropping, 0.33% to 4,269.84.
Via Benzinga · June 7, 2023

U.S. stocks traded mixed midway through trading, with Nasdaq Composite dropping over 100 points on Wednesday. The Dow traded up 0.20% to 33,639.18 while the NASDAQ fell 0.90% to 13,156.82. The S&P 500, also fell, dropping, 0.26% to 4,272.83.
Via Benzinga · June 7, 2023

U.S. stocks traded mixed this morning, with Dow Jones dropping around 20 points on Monday. Following the market opening Monday, the Dow traded down 0.06% to 33,740.98 while the NASDAQ rose 0.08% to 13,251.38. The S&P 500, also rose, gaining, 0.13% to 4,288.00.
Via Benzinga · June 5, 2023

U.S. stocks traded higher this morning, with the Dow Jones gaining over 50 points on Friday. Following the market opening Friday, the Dow traded up 0.17% to 33,594.20 while the NASDAQ rose 0.28% to 12,724.56. The S&P 500, also rose, gaining, 0.34% to 4,212.26.
Via Benzinga · May 19, 2023

U.S. stocks traded slightly lower midway through trading, with the Nasdaq Composite dropping around 20 points on Monday. The Dow traded down 0.14% to 33,626.85 while the NASDAQ fell 0.18% to 12,212.88. The S&P 500, also fell, dropping, 0.02% to 4,135.53.
Via Benzinga · May 8, 2023

Gainers TScan Therapeutics, Inc. (NASDAQ: TCRX) shares gained 118% to $4.68 after the company and Amgen announced collaboration to identify novel targets in Crohn's disease.
Via Benzinga · May 9, 2023